From Wisdomsofsilence 26/11/11 SP 46.5
"In this trial of difficult-to-treat patients, 82% were completely or partially healed with an average reduction in skin ulcer area of 56%. Given that these 44 patients had on average not responded to 3 years of expert care, these are superb results."
Superb results indeed that would not have gone un-noticed!
Its a matter of when, not if, a takeover is launched, and this announcement today facilitates that perfectly IMO, as has been alluded to in the ann:
"b) Enhanced position in merger / strategic alliance negotiations with pharma due to fully integrated
commercialisation infrastructure and lack of contractual restraints"
Value, page-37
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
